The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
1Pencil, people have been posting similar comments since it dropped through £3. I thought when it floated that fair value was £2, and bought at that level. This is now in falling knife territory and if those posters who seem to have been doubling up every few days were truthful in their posts then they are sitting on huge losses. Would not be surprised if it tested £1 now.
Continuing inability to deliver a persuasive investor update. Chair needed urgently or it will get worse. All those proclaiming that shorters will fry, as they have been saying for weeks, fail to grasp what is expected from a PLC and it is seriously lacking at THG.
As people have been saying for at least the past two months as the price has continued relentlessly downward. I took that view at £2.00 which had always been my buy-in price since IPO. Got that wrong and would not be surprised now to see it test £1.5O in the next few days. Heavyweight Chair is urgently needed to lead on investor communications which are frankly dreadful.
I watched both that and THG. Whilst GSK was poor, THG was the worst I have ever seen. The GSK share price fall was significant but not huge (as THG) and the recovery has been good but by no means super strong and still sits below historic figures and has under performed its competitors. There are few similarities between the two businesses. I have held GSK for 10 years as and bought into THG at what I believed to be fair value of £2. GSK sits in the core of my portfolio, THG in the speculative high risk/return part.
This business needs to assess how it is managing its corporate communications which is woeful by PLC standards and almost every single one takes the share price down. The analyst presentation that started this rout was the worst I had ever heard and I have little confidence that the results update will be better handled. I had always had £2.00 as my buy target since the IPO, a figure I thought represented fair value for a long term hold. Having traded at this level I now think I may have over estimated. Someone should have told him that playing the blame game is never well received so is he getting bad advice or just letting his ego over ride it? Urgently needs a street wise, investor savvy, Chair.
No it was mainly organic which, on the basis that research has shown that most acquisitions do not enhance value, could be considered a safer and slower route. It was however for a period a “darling stock” that defied all normal valuation techniques. Believe you are correct with 5p but that was well before it got on the radar of most.
Market cap still sits above ASOS. Remember that stock was once above 7000 with pundits talking of 12000 due to the growth potential. Never happened. Perhaps current valuation is not hugely out and what was wrong was the initial hype and IPO publicity which drove the price to unrealistic levels as it did with ASOS. Those heady days of 6000 seem a long way off with the price sub 2500.
Couple of non-execs bought as recently as October following the huge one day drop and are 50%+ down. People on this Board have been calling the bottom for over a month now it still keeps going down. Do not understand why they have not put out an RNS to give some confidence, there must be a reason.
Only agenda is to avoid people making mistakes by following individuals who talk up the price based only on their personal analysis. In every single example I gave, people were posting why it was different to others and the only way was up, and very substantially up. If the Boards are still available then individuals can check that what I am saying is correct. In one of the Boards there is a very sorry example of an individual who loss much more than he could afford
As people were posting yesterday and have been doing for weeks. A recovery is by no means certain and anyone new to investing should note that these Boards contained rapid recovery predictions for the likes of NMC, Debenhams, Afren, Carillion and many others. Always DYOR and remember these comments are only the opinions of individuals.
As so many posted about Sirius Minerals and Afren, before them, when their share prices fell. Beware catching a falling knife. This is a very high risk stock; not for widows, orphans or for a large percentage of any portfolio.
Pleased to see. Have been a holder for 10 years+ and sitting on a substantial loss.
Interesting to see that they specify that European investors prefer a share price over 1 euro, so they are going to achieve this by a share consolidation. Not too long ago that a price of over £1 was justified by trading. Remember this was a company whose Board turned down a £1.20 bid from Carlyle because it did not fully represent the value of the business. Amazing to think that at its peak share price was over £2.50. Will be interesting to see low the market judges what looks a slightly disappointing set of results, again.
I would not feel too sorry for new investors. The end result of Sirius minerals was well documented. Same sector but in a more political stable environment and that did not turn out well for those who thought it was a get rich quick route. These projects always take longer and cost much more cash and eventually the big boys with deep pockets can call the tune regardless of what existing investors want or think should happen. It was always very high risk.
In a similar position to you having bought in at c£27. Not selling but resisting the temptation to average down. I remember too well those posters on this site imploring people to buy, Afren, Debenhams, Carillion, Thomas Cook, Sirius Minerals and just last year FTSE100 NMC plus many others that were trading at a fraction of their all time highs. Ended very badly for any of those who took the postings at face value without doing their own analysis.